2
RC="/images/gifcha
rs/beta2.gif" BORDER=0 ALIGN="middle">-Ca
rbomethoxy-3
rs/beta2.gif" BORDER=0 ALIGN="middle">-(3'-((
Z)-2-iodoethenyl)phenyl)no
rt
ropane (
mZIENT,
1) and 2
rs/beta2.gif" BORDER=0 ALIGN="middle">-ca
rbomethoxy-3
rs/beta2.gif" BORDER=0 ALIGN="middle">-(3'-((
Z)-2-b
romoethenyl)phenyl)no
rt
ropane (
mZB
rENT,
2) we
re synthesized and evaluated fo
r binding to thehuman se
rotonin, dopamine, and no
repineph
rine t
ranspo
rte
rs (SERT, DAT, and NET,
respectively) usingt
ransfected cells. Both
1 and
2 have a high affinity fo
r the SERT (
Ki = 0.2 nM) and a
re ~160 times mo
reselective fo
r the SERT than the DAT. Compound
2 has a significantly highe
r affinity fo
r the NET than
1,and this may be a
result of the diffe
rent size and elect
ronegativity of the halogen atoms. Mic
roPET imagingin nonhuman p
rimates with [
11C]
1 and [
11C]
2 demonst
rated that both t
race
rs behave simila
rly in vivo withhigh uptake being obse
rved in the SERT-
rich b
rain
regions and peak uptake being achieved in about 55 minpostinjection. Chase studies with citalop
ram and methylphenidate demonst
rated that this uptake is the
resultof p
refe
rential binding to the SERT.